Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease - Heslegrave, Amanda; Heywood, Wendy; Paterson, Ross; Magdalinou, Nadia; Svensson, Johan; Johansson, Per; Öhrfelt, Annika; Blennow, Kaj; Hardy, John; Schott, Jonathan; Mills, Kevin; Zetterberg, Henrik (Molecular neurodegeneration, 2016)
Keywords: Aged; Aged, 80 and over; Alzheimer Disease - cerebrospinal fluid; Alzheimer Disease - diagnosis; Alzheimer Disease - genetics; Alzheimer's disease; Amyloid beta-Peptides - cerebrospinal fluid; Amyloid beta-Peptides - genetics; Apolipoprotein E4 - cerebrospinal fluid; Apolipoprotein E4 - genetics; Apolipoproteins; Biomarkers - analysis; Biomarkers - cerebrospinal fluid; Care and treatment; Complications and side effects; Development and progression; Enzyme-linked immunosorbent assay; Enzyme-Linked Immunosorbent Assay - methods; Female; Humans; Male; Membrane Glycoproteins - cerebrospinal fluid; Middle Aged; Neurosciences; Neurovetenskaper; Plaque, Amyloid - cerebrospinal fluid; Plaque, Amyloid - genetics; Receptors, Immunologic; Risk Factors; Short Report; tau Proteins - cerebrospinal fluid; tau Proteins - genetics; United States